An evaluation of zanubrutinib, a BTK inhibitor, for the treatment of chronic lymphocytic leukemia

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'An evaluation of zanubrutinib, a BTK inhibitor, for the treatment of chronic lymphocytic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences